142 related articles for article (PubMed ID: 11934595)
1. Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase. Part 2: Solid-phase optimization of side chains.
Dankwardt SM; Abbot SC; Broka CA; Martin RL; Chan CS; Springman EB; Van Wart HE; Walker KA
Bioorg Med Chem Lett; 2002 Apr; 12(8):1233-5. PubMed ID: 11934595
[TBL] [Abstract][Full Text] [Related]
2. Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues.
Dankwardt SM; Martin RL; Chan CS; Van Wart HE; Walker KA; Delaet NG; Robinson LA
Bioorg Med Chem Lett; 2001 Aug; 11(16):2085-8. PubMed ID: 11514144
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of procollagen C-terminal proteinase. Part 1: diamino Acid hydroxamates.
Delaet NG; Robinson LA; Wilson DM; Sullivan RW; Bradley EK; Dankwardt SM; Martin RL; Van Wart HE; Walker KA
Bioorg Med Chem Lett; 2003 Jul; 13(13):2101-4. PubMed ID: 12798313
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis of di- and tripeptidic hydroxamic acids as inhibitors of procollagen C-proteinase.
Dankwardt SM; Billedeau RJ; Lawley LK; Abbot SC; Martin RL; Chan CS; Van Wart HE; Walker KA
Bioorg Med Chem Lett; 2000 Nov; 10(22):2513-6. PubMed ID: 11086718
[TBL] [Abstract][Full Text] [Related]
5. Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.
Robinson LA; Wilson DM; Delaet NG; Bradley EK; Dankwardt SM; Campbell JA; Martin RL; Van Wart HE; Walker KA; Sullivan RW
Bioorg Med Chem Lett; 2003 Jul; 13(14):2381-4. PubMed ID: 12824039
[TBL] [Abstract][Full Text] [Related]
6. Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.
Hanessian S; Bouzbouz S; Boudon A; Tucker GC; Peyroulan D
Bioorg Med Chem Lett; 1999 Jun; 9(12):1691-6. PubMed ID: 10397503
[TBL] [Abstract][Full Text] [Related]
7. A novel series of highly selective inhibitors of MMP-3.
Whitlock GA; Dack KN; Dickinson RP; Lewis ML
Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
[TBL] [Abstract][Full Text] [Related]
8. Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
Levin JI; Gu Y; Nelson FC; Zask A; DiJoseph JF; Sharr MA; Sung A; Jin G; Cowling R; Chanda P; Cosmi S; Hsiao CL; Edris W; Wilhelm J; Killar LM; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):239-42. PubMed ID: 11206468
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of acidic dipeptide hydroxamate inhibitors of procollagen C-proteinase.
Ovens A; Joule JA; Kadler KE
J Pept Sci; 2000 Sep; 6(9):489-95. PubMed ID: 11016886
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.
Fish PV; Allan GA; Bailey S; Blagg J; Butt R; Collis MG; Greiling D; James K; Kendall J; McElroy A; McCleverty D; Reed C; Webster R; Whitlock GA
J Med Chem; 2007 Jul; 50(15):3442-56. PubMed ID: 17591762
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
Scozzafava A; Supuran CT
J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
[TBL] [Abstract][Full Text] [Related]
12. First insight into structure-activity relationships of selective meprin β inhibitors.
Ramsbeck D; Hamann A; Schlenzig D; Schilling S; Buchholz M
Bioorg Med Chem Lett; 2017 Jun; 27(11):2428-2431. PubMed ID: 28408220
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of procollagen C-proteinase inhibitors.
Turtle E; Chow N; Yang C; Sosa S; Bauer U; Brenner M; Solow-Cordero D; Ho WB
Bioorg Med Chem Lett; 2012 Dec; 22(24):7397-401. PubMed ID: 23134659
[TBL] [Abstract][Full Text] [Related]
14. Sulfonamide-based hydroxamic acids as potent inhibitors of mouse macrophage metalloelastase.
Jeng AY; Chou M; Parker DT
Bioorg Med Chem Lett; 1998 Apr; 8(8):897-902. PubMed ID: 9871508
[TBL] [Abstract][Full Text] [Related]
15. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.
Yang SM; Scannevin RH; Wang B; Burke SL; Huang Z; Karnachi P; Wilson LJ; Rhodes KJ; Lagu B; Murray WV
Bioorg Med Chem Lett; 2008 Feb; 18(3):1140-5. PubMed ID: 18083558
[TBL] [Abstract][Full Text] [Related]
16. Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.
Kottirsch G; Koch G; Feifel R; Neumann U
J Med Chem; 2002 May; 45(11):2289-93. PubMed ID: 12014967
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.
Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A
Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of procollagen C-terminal proteinase block gastrulation and spicule elongation in the sea urchin embryo.
Huggins LG; Lennarz WJ
Dev Growth Differ; 2001 Aug; 43(4):415-24. PubMed ID: 11473548
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
20. The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
Levin JI; Du MT; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Moy FJ; Powers R; Jin G; Cowling R; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):235-8. PubMed ID: 11206467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
